Short answer. CBGA is the shared precursor; a THCA synthase turns it into THCA and a CBDA synthase into CBDA. Which functional synthase a plant carries is inherited as one block, close to codominant. THC-dominant x CBD-dominant gives mixed F1s (roughly 1:1 to 1:2 THC:CBD); intercross those and you get about 1 THC : 2 mixed : 1 CBD. Mixed plants never breed true. How much total cannabinoid a plant makes is a separate, many-gene trait.
What's happening
- The pathway. CBGA sits at a fork. THCAS, CBDAS and CBCAS compete for it. If neither THCAS nor CBDAS works, CBGA builds up (chemotype IV) [2]. If CBGA itself is barely made (or trichome development fails), the plant is near cannabinoid-free (chemotype V) [8].
- The 2003 model. de Meijer et al. crossed inbred pure-THC and pure-CBD plants and explained the results with one locus, B, with codominant alleles B_T and B_D [1]. The F1 was uniformly mixed; F2s segregated 1:2:1.
- The genomic picture. THCAS and CBDAS are separate but closely linked genes, sitting in large (>250 kb), retrotransposon-rich, low-recombination regions that differ structurally between drug and hemp types [3][4]. In practice they still inherit together, so the one-locus model predicts well, but "B_T" and "B_D" are really haplotypes (gene blocks), not single genes. Non-functional copies and gene duplications exist [3].
- CBD in drug-type lines often traces to hemp introgressed into marijuana backgrounds [5] (Supported).
Chemotypes
| Chemotype | Typical ratio | Inferred synthase genotype | Breeds true? |
|---|---|---|---|
| I, THC dominant | THC:CBD > ~10:1 (often far higher) | B_T / B_T | Yes, for chemotype |
| II, mixed | ~0.5:1 to 3:1 | B_T / B_D | No: segregates 1:2:1 |
| III, CBD dominant | CBD:THC > ~10:1 (hemp lines often 20-30:1) | B_D / B_D | Yes, for chemotype |
| IV, CBG dominant | High CBG, low THC and CBD | Null (non-functional) synthase alleles, homozygous [2] | Yes, once homozygous |
| V, near zero | Trace cannabinoids | Pathway blocked upstream [8] | Yes |
Ratio boundaries are approximate and vary between studies [1][6]. Note: "CBD dominant" plants still make some THC; even good hemp lines show THC:CBD ratios around 1:20 to 1:30 because CBDAS itself makes a little THCAbeing reviewed.
Punnett square: THC x CBD
F1 (B_T/B_D) x F1 (B_T/B_D):
| B_T | B_D | |
|---|---|---|
| B_T | I (THC) | II (mixed) |
| B_D | II (mixed) | III (CBD) |
Backcross F1 (B_T/B_D) to the CBD parent (B_D/B_D): 1 mixed : 1 CBD. Two backcrosses with selection for type III recover a CBD-dominant line with the THC parent's other traits partly kept.
Step by step: breeding a stable CBD-dominant line
- Cross your THC-dominant selection (female) with a stable CBD-dominant male.
- Grow F1s; all should be type II. Any type I or III F1 means a parent wasn't homozygous.
- Choose the best F1 (or backcross to the CBD parent).
- In the F2 or BX1, screen seedlings with a chemotype DNA marker if available [7], or test a leaf or flower sample by chromatography.
- Keep only type III plants; select among them for the traits you want.
- Confirm the ratio with flower tests (same stage, same lab) on several plants of the final line.
Numbers that matter
| Population | Expected chemotype split |
|---|---|
| I x III (both homozygous) | 100% II |
| II x II | 25% I : 50% II : 25% III |
| II x III | 50% II : 50% III |
| II x I | 50% I : 50% II |
| Plants needed for 95% chance of ≥1 type III in an F2 | 11 (p = 0.25) |
| ...of ≥5 type III in an F2 | 34 (binomial, p = 0.25) |
Common mistakes
- Expecting a 1:1 cultivar to breed true. It is heterozygous by definition.
- Selecting "high THC" from small, single-run lab results. Total THC is quantitative and environment- and lab-sensitive.
- Assuming a seedling leaf test predicts the final ratio exactly. It predicts chemotype class well; ratios shift through flowering (Supported).
- Forgetting legal limits: in hemp jurisdictions, total THC limits apply to the crop, and type II segregants can exceed them.
Evidence
- Single inheritance unit, codominant model: Established [1], refined by genomics [3][4].
- CBG-dominant inheritance via null alleles: Established [2].
- Chemotype markers for seedling screening: Supported [7]; marker performance may vary by germplasm.
- Hemp introgression as a CBD source in drug-type lines: Supported [5].
